Lilly buys Alzheimer's imaging technology from Siemens
This article was originally published in Clinica
Executive Summary
In a sign that Eli Lilly & Co. is doubling down on Alzheimer’s research, the drug maker has acquired a pair of experimental brain imaging agents from Siemens.